-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhifei Biotech announced that the improved live attenuated vaccine for the Ankara pox virus monkeypox vaccine developed by its wholly-owned subsidiary Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd. has obtained a notice of acceptance of the drug clinical trial application from the State Drug Administration. The acceptance number is CXSL2501083. If no negative or questioning opinions have been received from the Drug Review Center within 60 days from the date of acceptance, Zhifeilong Koma may conduct clinical trials according to the submitted plan.

Zhitongcaijing·12/17/2025 08:41:06
Listen to the news
Zhifei Biotech announced that the improved live attenuated vaccine for the Ankara pox virus monkeypox vaccine developed by its wholly-owned subsidiary Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd. has obtained a notice of acceptance of the drug clinical trial application from the State Drug Administration. The acceptance number is CXSL2501083. If no negative or questioning opinions have been received from the Drug Review Center within 60 days from the date of acceptance, Zhifeilong Koma may conduct clinical trials according to the submitted plan.